Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol

NCT06845254 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins)
DRUG: placebo capsule

Sponsor

Xiyuan Hospital of China Academy of Chinese Medical Sciences